Korean cosmetics have moved from a regional trend to one of the world's largest beauty export categories. According to Korea's Ministry of Food and Drug Safety (MFDS), national cosmetics exports reached a record $11.4 billion in 2025 — up about 12% year on year — making Korea the world's second-largest cosmetics exporter after France. For overseas brands and manufacturers, this is not just a headline: it reshapes where ingredients, formulas and manufacturing capacity are coming from. This article summarizes the latest export data and what it means for anyone sourcing K-Beauty from abroad.
The headline numbers for 2025
The 2025 figures show a market that is both bigger and more diversified than before. The United States became the single largest destination for Korean cosmetics for the first time, overtaking China. At the same time, the number of destination countries expanded sharply, signaling demand well beyond the traditional East Asian markets.
| Metric | 2025 | Why it matters |
|---|---|---|
| Total exports | ~$11.4 billion (record high) | Korea is now the #2 exporter worldwide |
| Top market | United States (~$2.2B, ~19%) | US overtook China for the first time |
| China | ~$2.0 billion | Still large but no longer the single anchor |
| Japan | ~$1.1 billion | Steady, mature demand |
| Destination countries | ~202 (up from ~172) | Demand broadening into EU, Middle East, LATAM |
Why the shift toward the US and Europe matters for sourcing
When China was the dominant market, much of the K-Beauty supply chain optimized around a single buyer region. The 2025 data shows demand spreading across the United States, Europe, the Middle East and Latin America. For a brand or distributor, broader demand means Korean OEM/ODM factories and ingredient suppliers are now used to shipping globally and preparing export paperwork for multiple regulatory regimes — an advantage when you need a supplier who already understands US and EU requirements.
- More Korean suppliers now handle export documentation (CoA, MSDS, CFS) as routine, not as an exception
- Korea's leading role into the EU makes European compliance experience more common among factories
- A diversified export base tends to stabilize lead times and capacity for new overseas clients
- Ingredient innovation is pulled by global demand, not just the domestic Korean market
What global brands should take from the data
Record exports are a signal of maturity in the supply chain, not a reason to assume every supplier is export-ready. The practical takeaway is to treat Korea as a serious manufacturing base and to vet suppliers on the same criteria you would use anywhere: verifiable specifications, clean documentation, and the ability to support your target market's regulations. The upside is that the ecosystem — ingredient makers, ODM labs, packaging and logistics — has scaled with the export boom, so a well-run sourcing process has more capable partners to choose from than it did a few years ago.
- Start from the INCI name and a Certificate of Analysis, not a trade name or a marketing claim
- Confirm the supplier can provide the export documents your destination market requires
- Separate 'popular ingredient' from 'right grade for your product' — demand drives hype as well as quality
- Plan for regulatory lead time (US and EU notifications) as part of the launch timeline, not an afterthought
How MaterialB fits in
MaterialB is a Korean cosmetic-ingredient sourcing and OEM/ODM partner. Rather than reselling hype, we help overseas brands pin the right INCI, compare real specifications on paper, and run a clean RFQ with suppliers who can support export documentation. If the export data above describes a market you want to enter, the next step is a tighter sourcing brief — and that is exactly where we work.
Source and method: figures in this article are rewritten in our own words from publicly reported Korean cosmetics export data (MFDS/KOTRA export statistics and Korean industry news coverage for 2025). Numbers are rounded for readability and reflect reporting available at publication; this is market commentary, not investment or regulatory advice.